{"name":"Opexa Therapeutics, Inc.","slug":"opexa-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Tcelna","genericName":"Tcelna","slug":"tcelna","indication":"Other","status":"phase_2"},{"name":"Tovaxin","genericName":"Tovaxin","slug":"tovaxin","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Tcelna","genericName":"Tcelna","slug":"tcelna","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Tovaxin","genericName":"Tovaxin","slug":"tovaxin","phase":"discontinued","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxOSlZvRWx2eTJMMEJTRm1lVWpDZHctMlhOcDRmWnBEQkZsbDNySm9JSnY4R3BQY2NlbUd6QkFfM3RnMGt2TmxfUElKMXJWek5lWnJtdms1RUEzWWhPOWZiTzc5RHJkVUFURDVrN2Z0S0VsOGY3ZFV1U3hBWXluTnhPMzRwbmItWHg5U2Fnd2NXSmUwdERwNGhTR1BEVDlFYWl1TTZVWnJOci1oWF80NGhpUjBBVVBUN0ZBWG1MdjBsTGloYURvakhwN0ZUaGM1N19HUlRrb3hWaFFFN0VjOERYbUhsMy05Qklmb3UyaE94U0FHSjIxbHowZ3lQRUdYZl9zdjJqU1lRNURRQVhpZUpmeWduSEFVSENwY0FyVFFtUkZVSG9OcmRUeUtreDkzaV9uV2hVQg?oc=5","date":"2025-01-14","type":"pipeline","source":"prnewswire.com","summary":"Multiple Sclerosis Market in US to Grow by USD 4.99 Billion from 2025-2029, Driven by a Strong Vendor Pipeline and AI-Powered Market Evolution - Technavio - prnewswire.com","headline":"Multiple Sclerosis Market in US to Grow by USD 4.99 Billion from 2025-2029, Driven by a Strong Vendor Pipeline and AI-Po","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQOTM0UXFPa0ZVMGVQNDNMWEdQQkFDcWZ3RXNwVFg2WnNnVXpHNXNEMFkxblJtS3JiSXlLVF9fN2RlSmUtUlA0NmZoOG9sYjY3dEQyXzktZEZuSjJwNDkwWWROWmlVNG5YZWdHQTFrZ0tUbVI2bU9RNTdGejVMTkdsWGEyOUdvdjI5djhqRDBRdGNpR1JHVG5kd1NMZjcya0hFZ0xXMWlEdEZER3NEWTJMdU92NTdSc094b2lR?oc=5","date":"2024-10-03","type":"pipeline","source":"Spherical Insights","summary":"Top 5 Stem Cell Therapy Companies : Key Trends, Growth Drivers and Insights Report - Spherical Insights","headline":"Top 5 Stem Cell Therapy Companies : Key Trends, Growth Drivers and Insights Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE50bVN2SlRFSmpFT1dMODByZUdPMkFLaGtnWXJTQ3M2WG5IMUgtY3NoRElWcTl1Tm9zeU5HX3lnUDZKT19kNFF4WjBiLUtoX3A4UjVrOVlfUDJlRjhZc2dIU3AzNTItYkk?oc=5","date":"2023-05-07","type":"regulatory","source":"Market.us","summary":"Autologous Cell Therapy market Share, Demand | CAGR of 20.2% - Market.us","headline":"Autologous Cell Therapy market Share, Demand | CAGR of 20.2%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE5rVDFlam9Fd1Jvc0ZlaUR1a0wyZUtMc1lMSE1TdEQ3cnZBNDhfaklLcmtSTFFrSFc1SlZLem1rOEtqM2lFazY1bkVKU1l2ZndlMVc2TjRGakFzSXlwelc2YUF3?oc=5","date":"2022-11-02","type":"pipeline","source":"Straits Research","summary":"Stem Cells Market Size, Share, Growth | Industry Report, 2033 - Straits Research","headline":"Stem Cells Market Size, Share, Growth | Industry Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE4ySU1rZC1RVU1lRTBfemZ6NlZrWWVxVGR6OG1FVjY3aFM4UFdjUVQ0Y1FjZlM1aF85RkZ6UGxzdFFIYnJhWWNOUlJBcWltMlFyUTZMb0paaFdWN2NFUGpwRkV0R3V0UWJZNDBOeQ?oc=5","date":"2020-07-08","type":"pipeline","source":"Straits Research","summary":"Multiple Sclerosis Market Size, Share & Growth Report | Industry Report 2033 - Straits Research","headline":"Multiple Sclerosis Market Size, Share & Growth Report | Industry Report 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxOSGxLZWNabTVxT2RSazlrNzFHOGFKczREZTVKYV83RGNMMDNGOHhmLWhjVWVVcFo4VElVMV9uX3RvajlNYXNXSW5fSmQ1YXJ3SnFDbmJVVlgyMk1tVnNfY1VVMXEwTk12Nk5QS1RjSmhRRmVlSzZEa1Z5TGk3VnpHd21uQzVRMkdBWlNZYXduWDlQMVRJUXhJRjlKZ19qSlRNczR2VTVQRUdqTjBubDVQRHdnYWhCZDZLaGFBV3BPWXZHU24yb1ZmVlROZzN5TUdCN2NacFI3VTFrUFRFeHJhdmRrZWoyc1Z2UjJtTDZqbmpwcDlwajFpLUdDNWJvOTJBWENXcUZpSTdua1oyWmJtVmFHNlY4SjFLVFp5Nm1JX0NsQ283NVM1dTBIMUZoMkJCS1JURG1nWDZpSHo5TFM0d0JfOEl4Zw?oc=5","date":"2018-10-24","type":"deal","source":"prnewswire.com","summary":"Bioscience Pharma Partners, LLC (BPP) Announces Receipt of Key Patent, Appointment of Senior Executive, Engagement of PharmaVentures Ltd. and Participation at BioEurope 2018 - prnewswire.com","headline":"Bioscience Pharma Partners, LLC (BPP) Announces Receipt of Key Patent, Appointment of Senior Executive, Engagement of Ph","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOS2M5THE1aUk2OFdNZ21yNGI3dWdoRW9pcGRaZFNCRTRLTzlQZ25RVGZrMzl6d0dtS29SSTJQem5ocTFVN0hYQTRZZU91ZkRXWHdwQUVacGdzc2ZzR1pIQkVJeFp6VkF6UF81REpkY1FOTnBTOXRqOGIxZHVobko3Q1psbWR3RmE4ZXlmM3VNdXp6dmRVVXU3SXJpakJzbktVYzhRSUxOdjhmWVJ4akE?oc=5","date":"2017-02-01","type":"pipeline","source":"Fierce Pharma","summary":"CDMO KBI picks up cell therapy plant from struggling biotech Opexa - Fierce Pharma","headline":"CDMO KBI picks up cell therapy plant from struggling biotech Opexa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNTTllZ2dkcmdjbGNLN1BhcWlaOVMwWDV2a2lkU3N0ZS1TTEk4b0dBZHIwOFdfQlJ2SmRyWG9OTzA2ZGpmajlkUE1MdC14bS13cjBoYmFWVXNkQ09rdFljZ1p6Rmc3TEFfM0lNQkJPOUdUcjlEWVRjSVBmLTdnV1ZQSlo2RC1xT0VNRUdISWxYNXhTelY3MXJKZm94WFExMXJxS1VWWno3S1QwWmRUY3loNU10ZHZfSXR5M053NWZFckk2YUp1dDVRb1ZvMnl6R0ItalJ5d1RGQlFic1RPcEgyZg?oc=5","date":"2015-05-04","type":"pipeline","source":"Multiple Sclerosis News Today","summary":"EXCLUSIVE: Opexa Developing Tcelna as a True Personalized MS Therapy For SPMS, RRMS - Multiple Sclerosis News Today","headline":"EXCLUSIVE: Opexa Developing Tcelna as a True Personalized MS Therapy For SPMS, RRMS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPd0VfcnZBMFNsOWdia2Nxem1HNXUtakxyNExaUkxZTFQ1Q3F5WERib1RteEdmMHRQQmlHbDRxREVRbkxZeGdxRk9RckVRa1RkSkdQVE01LW1tQTRINW9KZmt1eVkxSWRWX0lwSEpXMG1VdUdvTXRpcEhPd3lrUFRPU09qZW40aVhqUEpaclozRWVFWXFqNUVXTHg1cDN2YnJ1cjd1azB5d2RvZUI2OV9odlF6SV95bG9VQXBURWRJMG05UEY2OU5OcXVoRzh3SUhROVkyQURwWnhCNWZWZF9tZmM1ZTllbDBIRXpOTzVPNEhEQVY1WHc?oc=5","date":"2007-05-19","type":"pipeline","source":"RTTNews","summary":"Pharma Sector: Few Newsmakers Of The Week - Pharmaxis, Celgene, Opexa, Genzyme, BioLineRx, Medarex, Boehringer, Acambis, Wyeth, Imclone - RTTNews","headline":"Pharma Sector: Few Newsmakers Of The Week - Pharmaxis, Celgene, Opexa, Genzyme, BioLineRx, Medarex, Boehringer, Acambis,","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"discontinued":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}